Article

The SARS-CoV-2 accessory factor ORF7a downregulates MHC class I surface expression

medRxiv · 2022 · Shuxuan Zheng, author Hendrik de Buhr, author Patrique Praest, author Anouk Evers, author Ingrid Brak-Boer, author Mariëlle van Grinsven, author Ylenia Longo, author Liset de Vries, author Wilco Nijenhuis, author Lukas C. Kapitein, author Jeffrey M. Beekman, author Monique Nijhuis, author Ingo Drexler, author Emmanuel J. H. J. Wiertz, author Robert Jan Lebbink, author

Key facts

Title The SARS-CoV-2 accessory factor ORF7a downregulates MHC class I surface expression
First author Shuxuan Zheng, author Hendrik de Buhr, author Patrique Praest, author Anouk Evers, author Ingrid Brak-Boer, author Mariëlle van Grinsven, author Ylenia Longo, author Liset de Vries, author Wilco Nijenhuis, author Lukas C. Kapitein, author Jeffrey M. Beekman, author Monique Nijhuis, author Ingo Drexler, author Emmanuel J. H. J. Wiertz, author Robert Jan Lebbink, author
Journal medRxiv
Published Jun 1, 2022
DOI 10.1101/2022.05.29.493850
Devices mentioned DEN000008, K022086, K042152, K103302, K914390, K940422, K981784, K982100
Product codes mentioned CFN, DDG, DFZ, NDS, JCI, KIP, KIT, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature